According to Global Cord Blood's latest financial reports the company's total assets are $1.34 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-03-31 | $1.34 B | 11.77% |
2021-03-31 | $1.20 B | 18.31% |
2020-03-31 | $1.01 B | 4.19% |
2019-03-31 | $0.97 B | 4.93% |
2018-03-31 | $0.93 B | 23.66% |
2017-03-31 | $0.75 B | 3.6% |
2016-03-31 | $0.72 B | 9.45% |
2015-03-31 | $0.66 B | 13.34% |
2014-03-31 | $0.58 B | 21.86% |
2013-03-31 | $0.48 B | 65.79% |
2012-03-31 | $0.28 B | 21.36% |
2011-03-31 | $0.23 B | 55.43% |
2010-03-31 | $0.15 B | |
2008-12-31 | $28.91 M | -15.54% |
2007-12-31 | $34.23 M | 1.61% |
2006-12-31 | $33.69 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
RadNet RDNT | $2.69 B | 100.06% | ๐บ๐ธ USA |
National Healthcare
NHC | $1.31 B | -2.53% | ๐บ๐ธ USA |
NeoGenomics
NEO | $1.68 B | 25.02% | ๐บ๐ธ USA |
Cryo-Cell CCEL | $61.22 M | -95.45% | ๐บ๐ธ USA |